

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fatty acid elongation (GO:0030497) | 7.29950890 |
| 2 | photoreceptor cell differentiation (GO:0046530) | 6.88105794 |
| 3 | eye photoreceptor cell differentiation (GO:0001754) | 6.88105794 |
| 4 | L-amino acid import (GO:0043092) | 6.13312914 |
| 5 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 6.10291292 |
| 6 | surfactant homeostasis (GO:0043129) | 6.09480920 |
| 7 | rhodopsin mediated signaling pathway (GO:0016056) | 5.87133406 |
| 8 | axon ensheathment in central nervous system (GO:0032291) | 5.84487094 |
| 9 | central nervous system myelination (GO:0022010) | 5.84487094 |
| 10 | transmission of nerve impulse (GO:0019226) | 5.79727726 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 5.75584021 |
| 12 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 5.45909112 |
| 13 | regulation of collateral sprouting (GO:0048670) | 5.13894247 |
| 14 | photoreceptor cell maintenance (GO:0045494) | 5.13555322 |
| 15 | negative regulation of axon extension (GO:0030517) | 4.92937978 |
| 16 | locomotory exploration behavior (GO:0035641) | 4.88121142 |
| 17 | myelination (GO:0042552) | 4.69074637 |
| 18 | chemical homeostasis within a tissue (GO:0048875) | 4.64551694 |
| 19 | ensheathment of neurons (GO:0007272) | 4.59818628 |
| 20 | axon ensheathment (GO:0008366) | 4.59818628 |
| 21 | neuronal ion channel clustering (GO:0045161) | 4.50248462 |
| 22 | activated T cell proliferation (GO:0050798) | 4.44605859 |
| 23 | import into cell (GO:0098657) | 4.41991818 |
| 24 | positive regulation of neurological system process (GO:0031646) | 4.40142829 |
| 25 | amino acid import (GO:0043090) | 4.36239738 |
| 26 | negative regulation of B cell mediated immunity (GO:0002713) | 4.31137938 |
| 27 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 4.31137938 |
| 28 | neuron remodeling (GO:0016322) | 4.18559793 |
| 29 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.15521377 |
| 30 | angiotensin maturation (GO:0002003) | 4.04994266 |
| 31 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.02823364 |
| 32 | response to hepatocyte growth factor (GO:0035728) | 4.02823364 |
| 33 | detection of light stimulus involved in visual perception (GO:0050908) | 4.01908335 |
| 34 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.01908335 |
| 35 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.98721926 |
| 36 | presynaptic membrane assembly (GO:0097105) | 3.95688336 |
| 37 | glycerophospholipid catabolic process (GO:0046475) | 3.94094971 |
| 38 | retinal cone cell development (GO:0046549) | 3.91479882 |
| 39 | negative regulation of axon guidance (GO:1902668) | 3.87069596 |
| 40 | regulation of transmission of nerve impulse (GO:0051969) | 3.82901941 |
| 41 | NADH metabolic process (GO:0006734) | 3.79971424 |
| 42 | virion attachment to host cell (GO:0019062) | 3.75600161 |
| 43 | adhesion of symbiont to host cell (GO:0044650) | 3.75600161 |
| 44 | carnitine shuttle (GO:0006853) | 3.70354832 |
| 45 | protein localization to cilium (GO:0061512) | 3.68435437 |
| 46 | regulation of extracellular matrix disassembly (GO:0010715) | 3.62011526 |
| 47 | semaphorin-plexin signaling pathway (GO:0071526) | 3.61995693 |
| 48 | regulation of axon regeneration (GO:0048679) | 3.61073022 |
| 49 | regulation of neuron projection regeneration (GO:0070570) | 3.61073022 |
| 50 | negative regulation of neurotransmitter secretion (GO:0046929) | 3.56752266 |
| 51 | single strand break repair (GO:0000012) | 3.53589631 |
| 52 | response to redox state (GO:0051775) | 3.48954628 |
| 53 | photoreceptor cell development (GO:0042461) | 3.48845023 |
| 54 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.45256582 |
| 55 | eye photoreceptor cell development (GO:0042462) | 3.44780977 |
| 56 | oligodendrocyte differentiation (GO:0048709) | 3.44173272 |
| 57 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.44015914 |
| 58 | positive regulation of gene expression, epigenetic (GO:0045815) | 3.43479497 |
| 59 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.42706301 |
| 60 | Rap protein signal transduction (GO:0032486) | 3.40251316 |
| 61 | positive regulation of actin filament depolymerization (GO:0030836) | 3.39270923 |
| 62 | adhesion of symbiont to host (GO:0044406) | 3.36399315 |
| 63 | peripheral nervous system development (GO:0007422) | 3.34852745 |
| 64 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.33175838 |
| 65 | cellular response to epinephrine stimulus (GO:0071872) | 3.32596429 |
| 66 | presynaptic membrane organization (GO:0097090) | 3.30624487 |
| 67 | axonal fasciculation (GO:0007413) | 3.30384441 |
| 68 | peripheral nervous system axon ensheathment (GO:0032292) | 3.29904800 |
| 69 | myelination in peripheral nervous system (GO:0022011) | 3.29904800 |
| 70 | phototransduction (GO:0007602) | 3.28691291 |
| 71 | limb bud formation (GO:0060174) | 3.27024512 |
| 72 | negative regulation of axonogenesis (GO:0050771) | 3.26354742 |
| 73 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.26086791 |
| 74 | detection of visible light (GO:0009584) | 3.25763485 |
| 75 | phototransduction, visible light (GO:0007603) | 3.24806135 |
| 76 | negative regulation of type 2 immune response (GO:0002829) | 3.20410301 |
| 77 | detection of light stimulus (GO:0009583) | 3.19843537 |
| 78 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.15382797 |
| 79 | cellular response to nitric oxide (GO:0071732) | 3.13850325 |
| 80 | actin-myosin filament sliding (GO:0033275) | 3.13245569 |
| 81 | muscle filament sliding (GO:0030049) | 3.13245569 |
| 82 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.12325612 |
| 83 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.08685323 |
| 84 | retina layer formation (GO:0010842) | 3.08139241 |
| 85 | peptide catabolic process (GO:0043171) | 3.06026536 |
| 86 | negative regulation of myoblast differentiation (GO:0045662) | 3.05437010 |
| 87 | fructose metabolic process (GO:0006000) | 3.05421121 |
| 88 | cellular response to reactive nitrogen species (GO:1902170) | 3.04470981 |
| 89 | substantia nigra development (GO:0021762) | 3.02614195 |
| 90 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.99806992 |
| 91 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.98680053 |
| 92 | negative regulation of cell killing (GO:0031342) | 2.98633656 |
| 93 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.98633656 |
| 94 | negative regulation of neurotransmitter transport (GO:0051589) | 2.97859661 |
| 95 | fatty acid transmembrane transport (GO:1902001) | 2.96994243 |
| 96 | very long-chain fatty acid metabolic process (GO:0000038) | 2.96938496 |
| 97 | DNA integration (GO:0015074) | 2.96934611 |
| 98 | cellular response to catecholamine stimulus (GO:0071870) | 2.96392457 |
| 99 | cellular response to monoamine stimulus (GO:0071868) | 2.96392457 |
| 100 | lipoprotein transport (GO:0042953) | 2.96365171 |
| 101 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.95292896 |
| 102 | regulation of guanylate cyclase activity (GO:0031282) | 2.93159070 |
| 103 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.93154726 |
| 104 | cell differentiation involved in metanephros development (GO:0072202) | 2.92272728 |
| 105 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.91053220 |
| 106 | response to epinephrine (GO:0071871) | 2.90863810 |
| 107 | synapse assembly (GO:0007416) | 2.89186098 |
| 108 | exploration behavior (GO:0035640) | 2.88106380 |
| 109 | actin-mediated cell contraction (GO:0070252) | 2.86396883 |
| 110 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.86007851 |
| 111 | negative regulation of complement activation (GO:0045916) | 2.84526278 |
| 112 | retinal rod cell development (GO:0046548) | 2.83773235 |
| 113 | neuron recognition (GO:0008038) | 2.83279535 |
| 114 | postsynaptic membrane organization (GO:0001941) | 2.82870504 |
| 115 | short-term memory (GO:0007614) | 2.82679958 |
| 116 | vitamin A metabolic process (GO:0006776) | 2.82414290 |
| 117 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.81731126 |
| 118 | regulation of axon guidance (GO:1902667) | 2.80342441 |
| 119 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.79912086 |
| 120 | visual perception (GO:0007601) | 2.78248478 |
| 121 | protein palmitoylation (GO:0018345) | 2.78208134 |
| 122 | negative regulation of protein localization to cell surface (GO:2000009) | 2.77774105 |
| 123 | sensory perception of light stimulus (GO:0050953) | 2.75834074 |
| 124 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.75577832 |
| 125 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.73103552 |
| 126 | neurotransmitter uptake (GO:0001504) | 2.72828668 |
| 127 | extracellular matrix assembly (GO:0085029) | 2.72436469 |
| 128 | nucleotide transmembrane transport (GO:1901679) | 2.70880883 |
| 129 | carnitine transmembrane transport (GO:1902603) | 2.70824883 |
| 130 | barbed-end actin filament capping (GO:0051016) | 2.70376024 |
| 131 | negative regulation of protein activation cascade (GO:2000258) | 2.70099261 |
| 132 | intestinal absorption (GO:0050892) | 2.68244101 |
| 133 | cGMP-mediated signaling (GO:0019934) | 2.64997738 |
| 134 | protein-lipid complex assembly (GO:0065005) | 2.62679431 |
| 135 | skeletal muscle adaptation (GO:0043501) | 2.60820151 |
| 136 | diacylglycerol metabolic process (GO:0046339) | 2.58589949 |
| 137 | glomerulus development (GO:0032835) | 2.58564564 |
| 138 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.57628487 |
| 139 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.57628487 |
| 140 | endocrine process (GO:0050886) | 2.57628487 |
| 141 | actin filament-based movement (GO:0030048) | 2.55976622 |
| 142 | fibril organization (GO:0097435) | 2.55974459 |
| 143 | macroautophagy (GO:0016236) | 2.55575658 |
| 144 | response to nitric oxide (GO:0071731) | 2.55045668 |
| 145 | regulation of skeletal muscle contraction (GO:0014819) | 2.54401688 |
| 146 | regulation of bile acid biosynthetic process (GO:0070857) | 2.54112890 |
| 147 | skeletal muscle contraction (GO:0003009) | 2.52213755 |
| 148 | venous blood vessel morphogenesis (GO:0048845) | 2.50595045 |
| 149 | negative regulation of fatty acid transport (GO:2000192) | 2.50465992 |
| 150 | type B pancreatic cell proliferation (GO:0044342) | 2.49833424 |
| 151 | hormone catabolic process (GO:0042447) | 2.48336642 |
| 152 | regulation of necroptotic process (GO:0060544) | 2.45815515 |
| 153 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.40754882 |
| 154 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.38792521 |
| 155 | negative regulation of humoral immune response (GO:0002921) | 2.38658793 |
| 156 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.37319165 |
| 157 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.37319165 |
| 158 | cell migration involved in heart development (GO:0060973) | 2.36419982 |
| 159 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.34963131 |
| 160 | protein carboxylation (GO:0018214) | 2.34963131 |
| 161 | steroid hormone mediated signaling pathway (GO:0043401) | 2.33491378 |
| 162 | endocardial cushion development (GO:0003197) | 2.33189017 |
| 163 | creatine metabolic process (GO:0006600) | 2.32589899 |
| 164 | regulation of extracellular matrix organization (GO:1903053) | 2.31375063 |
| 165 | negative regulation of osteoblast differentiation (GO:0045668) | 2.30633476 |
| 166 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.30259233 |
| 167 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.29091256 |
| 168 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.28706596 |
| 169 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.27269923 |
| 170 | response to muscle activity (GO:0014850) | 2.26281621 |
| 171 | plasma lipoprotein particle assembly (GO:0034377) | 2.24838977 |
| 172 | myofibril assembly (GO:0030239) | 2.24403269 |
| 173 | embryonic process involved in female pregnancy (GO:0060136) | 2.23965976 |
| 174 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.23739709 |
| 175 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.21808100 |
| 176 | regulation of systemic arterial blood pressure (GO:0003073) | 2.21075193 |
| 177 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.20908405 |
| 178 | positive regulation of extracellular matrix organization (GO:1903055) | 2.20713144 |
| 179 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.19394056 |
| 180 | regulation of triglyceride catabolic process (GO:0010896) | 2.18657246 |
| 181 | positive regulation of receptor recycling (GO:0001921) | 2.16130268 |
| 182 | glucan catabolic process (GO:0009251) | 2.16074061 |
| 183 | actin filament depolymerization (GO:0030042) | 2.15752364 |
| 184 | regulation of pseudopodium assembly (GO:0031272) | 2.15441857 |
| 185 | regulation of complement activation (GO:0030449) | 2.14282693 |
| 186 | retinoic acid receptor signaling pathway (GO:0048384) | 2.14115178 |
| 187 | regulation of cholesterol homeostasis (GO:2000188) | 2.13117924 |
| 188 | positive regulation of lipid catabolic process (GO:0050996) | 2.11110839 |
| 189 | negative regulation of peptidyl-serine phosphorylation (GO:0033137) | 2.10823713 |
| 190 | protein heterotrimerization (GO:0070208) | 2.10713293 |
| 191 | positive regulation of gastrulation (GO:2000543) | 2.10582319 |
| 192 | extracellular fibril organization (GO:0043206) | 2.09454869 |
| 193 | blood vessel maturation (GO:0001955) | 2.08120004 |
| 194 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.07983248 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.63919478 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.54264266 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.25702529 |
| 4 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.84698912 |
| 5 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.75976964 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.59302506 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.39853040 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.37139286 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.35600291 |
| 10 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.34725560 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.29296681 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.27482452 |
| 13 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.21494850 |
| 14 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.17760680 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.11097091 |
| 16 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.00295679 |
| 17 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.99643455 |
| 18 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.99560366 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.97309217 |
| 20 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.95928692 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.94838495 |
| 22 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.93616485 |
| 23 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.92764202 |
| 24 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.92764202 |
| 25 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.92362921 |
| 26 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.92042425 |
| 27 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.91004444 |
| 28 | P300_19829295_ChIP-Seq_ESCs_Human | 1.88866377 |
| 29 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.86019486 |
| 30 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.84820188 |
| 31 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.78960996 |
| 32 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.78557935 |
| 33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.78299470 |
| 34 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.75864076 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.74449394 |
| 36 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74383095 |
| 37 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.74201375 |
| 38 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.74113869 |
| 39 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.73955065 |
| 40 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.71680491 |
| 41 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.70301350 |
| 42 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.67255735 |
| 43 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.67086031 |
| 44 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.66544688 |
| 45 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.66390736 |
| 46 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.65379956 |
| 47 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.64292835 |
| 48 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.64178563 |
| 49 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.63185641 |
| 50 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.61746957 |
| 51 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.59902074 |
| 52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58022379 |
| 53 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.57401479 |
| 54 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.57059573 |
| 55 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.56176506 |
| 56 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.55502962 |
| 57 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.55358173 |
| 58 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.54545325 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.53421230 |
| 60 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.52945217 |
| 61 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.51222846 |
| 62 | VDR_22108803_ChIP-Seq_LS180_Human | 1.50287676 |
| 63 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.49839406 |
| 64 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.49690450 |
| 65 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.48853272 |
| 66 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47362840 |
| 67 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.45913569 |
| 68 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.45300626 |
| 69 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45284625 |
| 70 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.44707486 |
| 71 | FUS_26573619_Chip-Seq_HEK293_Human | 1.43258165 |
| 72 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41149428 |
| 73 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.41059078 |
| 74 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.41059078 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.39819045 |
| 76 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.38731360 |
| 77 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38433532 |
| 78 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.38110044 |
| 79 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.36726101 |
| 80 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.36641575 |
| 81 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.35904359 |
| 82 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35344211 |
| 83 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.35299206 |
| 84 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.34817553 |
| 85 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.34099619 |
| 86 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.34077076 |
| 87 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.32359758 |
| 88 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.31982401 |
| 89 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.31781595 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.30852139 |
| 91 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.30378045 |
| 92 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30222877 |
| 93 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.29352982 |
| 94 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29050781 |
| 95 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.27799547 |
| 96 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.27536111 |
| 97 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.26919423 |
| 98 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.26631367 |
| 99 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26604963 |
| 100 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.26431334 |
| 101 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.25751785 |
| 102 | SA1_27219007_Chip-Seq_Bcells_Human | 1.25746052 |
| 103 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.25417108 |
| 104 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.25334803 |
| 105 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.25083159 |
| 106 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24367682 |
| 107 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.23059995 |
| 108 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.23030059 |
| 109 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.22470113 |
| 110 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.22292059 |
| 111 | KDM2B_26808549_Chip-Seq_K562_Human | 1.20907087 |
| 112 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20493038 |
| 113 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20462444 |
| 114 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.19960332 |
| 115 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.19888635 |
| 116 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.19748817 |
| 117 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.19561200 |
| 118 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 1.19464597 |
| 119 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.19424032 |
| 120 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18177924 |
| 121 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.18058804 |
| 122 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.17978452 |
| 123 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.17939664 |
| 124 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.16441954 |
| 125 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.16066125 |
| 126 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.15799268 |
| 127 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.15173911 |
| 128 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14331096 |
| 129 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.14274247 |
| 130 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.14240644 |
| 131 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.14163036 |
| 132 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.13928611 |
| 133 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13888017 |
| 134 | CJUN_26792858_Chip-Seq_BT549_Human | 1.13405248 |
| 135 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.12541148 |
| 136 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12397417 |
| 137 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12350101 |
| 138 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.11907995 |
| 139 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.11847035 |
| 140 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.11613694 |
| 141 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11275032 |
| 142 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11156365 |
| 143 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.11145062 |
| 144 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.10110218 |
| 145 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.09639111 |
| 146 | JUN_21703547_ChIP-Seq_K562_Human | 1.09591834 |
| 147 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09494075 |
| 148 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.09313977 |
| 149 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.08967940 |
| 150 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.08261490 |
| 151 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.08102428 |
| 152 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07733155 |
| 153 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06540038 |
| 154 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.06540038 |
| 155 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06337397 |
| 156 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.06275831 |
| 157 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04792016 |
| 158 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03820939 |
| 159 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00596929 |
| 160 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.00347911 |
| 161 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.99748785 |
| 162 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.98566596 |
| 163 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.98499011 |
| 164 | GATA1_22025678_ChIP-Seq_K562_Human | 0.96867863 |
| 165 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.96812544 |
| 166 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.96625823 |
| 167 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.96495654 |
| 168 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.96062717 |
| 169 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.94821939 |
| 170 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93952198 |
| 171 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.92798610 |
| 172 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.91944019 |
| 173 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.91433714 |
| 174 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.91284251 |
| 175 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90883155 |
| 176 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.90806511 |
| 177 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90379873 |
| 178 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.90299288 |
| 179 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.89986238 |
| 180 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.89304634 |
| 181 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89109620 |
| 182 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.88509756 |
| 183 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86283450 |
| 184 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.85617107 |
| 185 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.85061734 |
| 186 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.84840536 |
| 187 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.84132235 |
| 188 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.84132235 |
| 189 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.81100376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003011_delayed_dark_adaptation | 5.19000424 |
| 2 | MP0001958_emphysema | 4.98201389 |
| 3 | MP0005551_abnormal_eye_electrophysiolog | 4.93837115 |
| 4 | MP0005360_urolithiasis | 4.40758194 |
| 5 | MP0003690_abnormal_glial_cell | 3.45589000 |
| 6 | MP0006072_abnormal_retinal_apoptosis | 3.44737060 |
| 7 | MP0000920_abnormal_myelination | 3.32272293 |
| 8 | MP0005253_abnormal_eye_physiology | 3.31271779 |
| 9 | MP0005171_absent_coat_pigmentation | 3.22776804 |
| 10 | MP0005423_abnormal_somatic_nervous | 3.17463498 |
| 11 | MP0003880_abnormal_central_pattern | 3.11811861 |
| 12 | MP0003705_abnormal_hypodermis_morpholog | 2.91358966 |
| 13 | MP0000751_myopathy | 2.90787762 |
| 14 | MP0005503_abnormal_tendon_morphology | 2.76261983 |
| 15 | MP0002272_abnormal_nervous_system | 2.69346727 |
| 16 | MP0002822_catalepsy | 2.61062436 |
| 17 | MP0002064_seizures | 2.53916918 |
| 18 | MP0005248_abnormal_Harderian_gland | 2.50574285 |
| 19 | MP0001986_abnormal_taste_sensitivity | 2.48832480 |
| 20 | MP0005275_abnormal_skin_tensile | 2.48375897 |
| 21 | MP0003635_abnormal_synaptic_transmissio | 2.37043803 |
| 22 | MP0001486_abnormal_startle_reflex | 2.32520748 |
| 23 | MP0004859_abnormal_synaptic_plasticity | 2.29096867 |
| 24 | MP0005195_abnormal_posterior_eye | 2.24569126 |
| 25 | MP0004134_abnormal_chest_morphology | 2.22768098 |
| 26 | MP0001324_abnormal_eye_pigmentation | 2.20770897 |
| 27 | MP0003183_abnormal_peptide_metabolism | 2.20237368 |
| 28 | MP0002229_neurodegeneration | 2.18677330 |
| 29 | MP0004742_abnormal_vestibular_system | 2.16769214 |
| 30 | MP0001529_abnormal_vocalization | 2.16183242 |
| 31 | MP0004036_abnormal_muscle_relaxation | 2.12217289 |
| 32 | MP0003279_aneurysm | 2.10335071 |
| 33 | MP0009745_abnormal_behavioral_response | 2.09741583 |
| 34 | MP0004270_analgesia | 2.07030398 |
| 35 | MP0002090_abnormal_vision | 2.05915252 |
| 36 | MP0000566_synostosis | 2.05636569 |
| 37 | MP0004381_abnormal_hair_follicle | 2.00423677 |
| 38 | MP0005451_abnormal_body_composition | 1.99787820 |
| 39 | MP0005408_hypopigmentation | 1.94353544 |
| 40 | MP0000749_muscle_degeneration | 1.94074572 |
| 41 | MP0004885_abnormal_endolymph | 1.90141538 |
| 42 | MP0001485_abnormal_pinna_reflex | 1.84912994 |
| 43 | MP0000462_abnormal_digestive_system | 1.82255466 |
| 44 | MP0009384_cardiac_valve_regurgitation | 1.82117517 |
| 45 | MP0009840_abnormal_foam_cell | 1.73002315 |
| 46 | MP0004019_abnormal_vitamin_homeostasis | 1.71875040 |
| 47 | MP0002752_abnormal_somatic_nervous | 1.71708791 |
| 48 | MP0002736_abnormal_nociception_after | 1.69483743 |
| 49 | MP0003646_muscle_fatigue | 1.68802059 |
| 50 | MP0006054_spinal_hemorrhage | 1.68563434 |
| 51 | MP0003879_abnormal_hair_cell | 1.67511510 |
| 52 | MP0003634_abnormal_glial_cell | 1.67277576 |
| 53 | MP0003724_increased_susceptibility_to | 1.66696892 |
| 54 | MP0004272_abnormal_basement_membrane | 1.65862617 |
| 55 | MP0001968_abnormal_touch/_nociception | 1.61587735 |
| 56 | MP0000778_abnormal_nervous_system | 1.59229948 |
| 57 | MP0001905_abnormal_dopamine_level | 1.58867236 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.58354930 |
| 59 | MP0002882_abnormal_neuron_morphology | 1.55372450 |
| 60 | MP0002108_abnormal_muscle_morphology | 1.53724910 |
| 61 | MP0005085_abnormal_gallbladder_physiolo | 1.53191306 |
| 62 | MP0001501_abnormal_sleep_pattern | 1.52843720 |
| 63 | MP0005670_abnormal_white_adipose | 1.51098864 |
| 64 | MP0005365_abnormal_bile_salt | 1.50049119 |
| 65 | MP0002933_joint_inflammation | 1.49829838 |
| 66 | MP0008438_abnormal_cutaneous_collagen | 1.49818147 |
| 67 | MP0001177_atelectasis | 1.45638804 |
| 68 | MP0006292_abnormal_olfactory_placode | 1.44443866 |
| 69 | MP0005391_vision/eye_phenotype | 1.44044075 |
| 70 | MP0005058_abnormal_lysosome_morphology | 1.43046270 |
| 71 | MP0000759_abnormal_skeletal_muscle | 1.41810828 |
| 72 | MP0002063_abnormal_learning/memory/cond | 1.40085544 |
| 73 | MP0002067_abnormal_sensory_capabilities | 1.39020012 |
| 74 | MP0002572_abnormal_emotion/affect_behav | 1.38508651 |
| 75 | MP0005023_abnormal_wound_healing | 1.37431239 |
| 76 | MP0000747_muscle_weakness | 1.36121356 |
| 77 | MP0002295_abnormal_pulmonary_circulatio | 1.33364762 |
| 78 | MP0003632_abnormal_nervous_system | 1.31982028 |
| 79 | MP0001666_abnormal_nutrient_absorption | 1.30660554 |
| 80 | MP0001346_abnormal_lacrimal_gland | 1.30640845 |
| 81 | MP0004130_abnormal_muscle_cell | 1.27079490 |
| 82 | MP0004782_abnormal_surfactant_physiolog | 1.26921709 |
| 83 | MP0001984_abnormal_olfaction | 1.26797665 |
| 84 | MP0003436_decreased_susceptibility_to | 1.26314025 |
| 85 | MP0003191_abnormal_cellular_cholesterol | 1.26308241 |
| 86 | MP0002102_abnormal_ear_morphology | 1.25772579 |
| 87 | MP0001851_eye_inflammation | 1.25512550 |
| 88 | MP0006138_congestive_heart_failure | 1.23655042 |
| 89 | MP0001963_abnormal_hearing_physiology | 1.22672400 |
| 90 | MP0002106_abnormal_muscle_physiology | 1.22419720 |
| 91 | MP0000767_abnormal_smooth_muscle | 1.21961236 |
| 92 | MP0010329_abnormal_lipoprotein_level | 1.20860458 |
| 93 | MP0009780_abnormal_chondrocyte_physiolo | 1.19972220 |
| 94 | MP0002971_abnormal_brown_adipose | 1.19956826 |
| 95 | MP0005257_abnormal_intraocular_pressure | 1.19682150 |
| 96 | MP0001440_abnormal_grooming_behavior | 1.18838199 |
| 97 | MP0005369_muscle_phenotype | 1.17979311 |
| 98 | MP0010386_abnormal_urinary_bladder | 1.15377694 |
| 99 | MP0009046_muscle_twitch | 1.12964280 |
| 100 | MP0002998_abnormal_bone_remodeling | 1.12522716 |
| 101 | MP0004087_abnormal_muscle_fiber | 1.12356842 |
| 102 | MP0010368_abnormal_lymphatic_system | 1.12051488 |
| 103 | MP0002734_abnormal_mechanical_nocicepti | 1.11723296 |
| 104 | MP0008004_abnormal_stomach_pH | 1.11631572 |
| 105 | MP0001533_abnormal_skeleton_physiology | 1.11606404 |
| 106 | MP0005620_abnormal_muscle_contractility | 1.09277837 |
| 107 | MP0006276_abnormal_autonomic_nervous | 1.09074795 |
| 108 | MP0005075_abnormal_melanosome_morpholog | 1.06391541 |
| 109 | MP0005409_darkened_coat_color | 1.06109035 |
| 110 | MP0003300_gastrointestinal_ulcer | 1.06013547 |
| 111 | MP0001542_abnormal_bone_strength | 1.05874313 |
| 112 | MP0001727_abnormal_embryo_implantation | 1.04550541 |
| 113 | MP0004924_abnormal_behavior | 1.04043751 |
| 114 | MP0005386_behavior/neurological_phenoty | 1.04043751 |
| 115 | MP0002896_abnormal_bone_mineralization | 1.02170472 |
| 116 | MP0001664_abnormal_digestion | 1.02016478 |
| 117 | MP0000026_abnormal_inner_ear | 1.01893750 |
| 118 | MP0003172_abnormal_lysosome_physiology | 1.00053196 |
| 119 | MP0002066_abnormal_motor_capabilities/c | 0.99844463 |
| 120 | MP0002557_abnormal_social/conspecific_i | 0.99037021 |
| 121 | MP0010155_abnormal_intestine_physiology | 0.98232897 |
| 122 | MP0003136_yellow_coat_color | 0.97285521 |
| 123 | MP0005197_abnormal_uvea_morphology | 0.96709687 |
| 124 | MP0008569_lethality_at_weaning | 0.95318383 |
| 125 | MP0000013_abnormal_adipose_tissue | 0.95160303 |
| 126 | MP0003938_abnormal_ear_development | 0.93758021 |
| 127 | MP0003866_abnormal_defecation | 0.92089395 |
| 128 | MP0003950_abnormal_plasma_membrane | 0.92019989 |
| 129 | MP0000733_abnormal_muscle_development | 0.91692672 |
| 130 | MP0004084_abnormal_cardiac_muscle | 0.90127256 |
| 131 | MP0001661_extended_life_span | 0.90047647 |
| 132 | MP0002139_abnormal_hepatobiliary_system | 0.89694554 |
| 133 | MP0001502_abnormal_circadian_rhythm | 0.89411119 |
| 134 | MP0005666_abnormal_adipose_tissue | 0.88590086 |
| 135 | MP0005595_abnormal_vascular_smooth | 0.88385062 |
| 136 | MP0003091_abnormal_cell_migration | 0.87490212 |
| 137 | MP0008260_abnormal_autophagy | 0.86018729 |
| 138 | MP0000750_abnormal_muscle_regeneration | 0.84860270 |
| 139 | MP0006082_CNS_inflammation | 0.84826836 |
| 140 | MP0000955_abnormal_spinal_cord | 0.84101797 |
| 141 | MP0005390_skeleton_phenotype | 0.82103749 |
| 142 | MP0002127_abnormal_cardiovascular_syste | 0.81854684 |
| 143 | MP0002184_abnormal_innervation | 0.81356261 |
| 144 | MP0003566_abnormal_cell_adhesion | 0.81051778 |
| 145 | MP0002837_dystrophic_cardiac_calcinosis | 0.80467416 |
| 146 | MP0003631_nervous_system_phenotype | 0.80332891 |
| 147 | MP0003045_fibrosis | 0.80106654 |
| 148 | MP0000631_abnormal_neuroendocrine_gland | 0.77886635 |
| 149 | MP0000230_abnormal_systemic_arterial | 0.77609370 |
| 150 | MP0003828_pulmonary_edema | 0.74758907 |
| 151 | MP0002269_muscular_atrophy | 0.74100312 |
| 152 | MP0002234_abnormal_pharynx_morphology | 0.73381886 |
| 153 | MP0000249_abnormal_blood_vessel | 0.72902478 |
| 154 | MP0003252_abnormal_bile_duct | 0.72308950 |
| 155 | MP0002909_abnormal_adrenal_gland | 0.72228779 |
| 156 | MP0005164_abnormal_response_to | 0.72222003 |
| 157 | MP0005330_cardiomyopathy | 0.71566530 |
| 158 | MP0002118_abnormal_lipid_homeostasis | 0.70840652 |
| 159 | MP0001299_abnormal_eye_distance/ | 0.69196327 |
| 160 | MP0005508_abnormal_skeleton_morphology | 0.69080075 |
| 161 | MP0004233_abnormal_muscle_weight | 0.68087896 |
| 162 | MP0004142_abnormal_muscle_tone | 0.67710848 |
| 163 | MP0002332_abnormal_exercise_endurance | 0.67469282 |
| 164 | MP0009643_abnormal_urine_homeostasis | 0.67009234 |
| 165 | MP0000383_abnormal_hair_follicle | 0.67001079 |
| 166 | MP0010030_abnormal_orbit_morphology | 0.66065477 |
| 167 | MP0003137_abnormal_impulse_conducting | 0.64070326 |
| 168 | MP0005499_abnormal_olfactory_system | 0.63392697 |
| 169 | MP0005394_taste/olfaction_phenotype | 0.63392697 |
| 170 | MP0003195_calcinosis | 0.62069430 |
| 171 | MP0002751_abnormal_autonomic_nervous | 0.61763028 |
| 172 | MP0002152_abnormal_brain_morphology | 0.61563492 |
| 173 | MP0004145_abnormal_muscle_electrophysio | 0.61075698 |
| 174 | MP0004185_abnormal_adipocyte_glucose | 0.61053863 |
| 175 | MP0003890_abnormal_embryonic-extraembry | 0.59823444 |
| 176 | MP0002638_abnormal_pupillary_reflex | 0.59720972 |
| 177 | MP0001970_abnormal_pain_threshold | 0.58000538 |
| 178 | MP0003329_amyloid_beta_deposits | 0.54638805 |
| 179 | MP0005388_respiratory_system_phenotype | 0.54468686 |
| 180 | MP0002133_abnormal_respiratory_system | 0.54468686 |
| 181 | MP0003633_abnormal_nervous_system | 0.52318365 |
| 182 | MP0002735_abnormal_chemical_nociception | 0.51473039 |
| 183 | MP0004858_abnormal_nervous_system | 0.49888239 |
| 184 | MP0000762_abnormal_tongue_morphology | 0.49527973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dyschromatopsia (HP:0007641) | 6.68210907 |
| 2 | Congenital stationary night blindness (HP:0007642) | 6.36792111 |
| 3 | Decreased central vision (HP:0007663) | 6.18806450 |
| 4 | Central scotoma (HP:0000603) | 6.01936309 |
| 5 | Sensory axonal neuropathy (HP:0003390) | 5.99465615 |
| 6 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 5.70752540 |
| 7 | Abnormality of macular pigmentation (HP:0008002) | 5.63568327 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 5.43510670 |
| 9 | Subcapsular cataract (HP:0000523) | 5.42734117 |
| 10 | Abnormal rod and cone electroretinograms (HP:0008323) | 5.09110400 |
| 11 | Abolished electroretinogram (ERG) (HP:0000550) | 4.99870559 |
| 12 | Bony spicule pigmentary retinopathy (HP:0007737) | 4.73871718 |
| 13 | Nemaline bodies (HP:0003798) | 4.72883489 |
| 14 | Muscle fiber inclusion bodies (HP:0100299) | 4.67892616 |
| 15 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.62407376 |
| 16 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.62407376 |
| 17 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.52718159 |
| 18 | Protrusio acetabuli (HP:0003179) | 4.46793589 |
| 19 | Scotoma (HP:0000575) | 4.45159701 |
| 20 | Cone-rod dystrophy (HP:0000548) | 4.40370449 |
| 21 | Premature skin wrinkling (HP:0100678) | 4.39964701 |
| 22 | Chorioretinal atrophy (HP:0000533) | 4.24205704 |
| 23 | Aortic aneurysm (HP:0004942) | 4.04337146 |
| 24 | Atonic seizures (HP:0010819) | 3.94158876 |
| 25 | Pigmentary retinal degeneration (HP:0001146) | 3.91687401 |
| 26 | Exercise-induced myalgia (HP:0003738) | 3.91179647 |
| 27 | Peripheral hypomyelination (HP:0007182) | 3.89462759 |
| 28 | Pendular nystagmus (HP:0012043) | 3.75800307 |
| 29 | Polar cataract (HP:0010696) | 3.74116432 |
| 30 | Hydroxyprolinuria (HP:0003080) | 3.50695679 |
| 31 | Abnormality of proline metabolism (HP:0010907) | 3.50695679 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.39313093 |
| 33 | Abnormality of the corticospinal tract (HP:0002492) | 3.38841630 |
| 34 | Attenuation of retinal blood vessels (HP:0007843) | 3.28462075 |
| 35 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.26620233 |
| 36 | Small epiphyses (HP:0010585) | 3.22625873 |
| 37 | Increased variability in muscle fiber diameter (HP:0003557) | 3.20130619 |
| 38 | Macular degeneration (HP:0000608) | 3.16360857 |
| 39 | Premature rupture of membranes (HP:0001788) | 3.15864843 |
| 40 | Cerebral hypomyelination (HP:0006808) | 3.12398181 |
| 41 | Systemic lupus erythematosus (HP:0002725) | 3.12119724 |
| 42 | Round ear (HP:0100830) | 3.10142403 |
| 43 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.09721700 |
| 44 | Absent/shortened dynein arms (HP:0200106) | 3.09721700 |
| 45 | Aortic dissection (HP:0002647) | 3.02883299 |
| 46 | Increased corneal curvature (HP:0100692) | 3.01503349 |
| 47 | Keratoconus (HP:0000563) | 3.01503349 |
| 48 | Vascular tortuosity (HP:0004948) | 3.00053650 |
| 49 | Increased connective tissue (HP:0009025) | 2.94627791 |
| 50 | Myopathic facies (HP:0002058) | 2.91324113 |
| 51 | Stage 5 chronic kidney disease (HP:0003774) | 2.73051197 |
| 52 | Esophageal atresia (HP:0002032) | 2.71169395 |
| 53 | Retinal dysplasia (HP:0007973) | 2.67368284 |
| 54 | Ulnar deviation of the wrist (HP:0003049) | 2.66822575 |
| 55 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.66746916 |
| 56 | Deep palmar crease (HP:0006191) | 2.64612925 |
| 57 | Asymmetric septal hypertrophy (HP:0001670) | 2.64334586 |
| 58 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.63675451 |
| 59 | Interstitial pulmonary disease (HP:0006530) | 2.63419068 |
| 60 | Alacrima (HP:0000522) | 2.61311127 |
| 61 | Slender build (HP:0001533) | 2.58322004 |
| 62 | Distal lower limb muscle weakness (HP:0009053) | 2.55952717 |
| 63 | Photophobia (HP:0000613) | 2.53820613 |
| 64 | Arterial tortuosity (HP:0005116) | 2.53369533 |
| 65 | Morphological abnormality of the inner ear (HP:0011390) | 2.53206535 |
| 66 | Neck muscle weakness (HP:0000467) | 2.50125752 |
| 67 | Muscle fiber splitting (HP:0003555) | 2.49497798 |
| 68 | Vertebral compression fractures (HP:0002953) | 2.48563866 |
| 69 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.47385694 |
| 70 | Distal arthrogryposis (HP:0005684) | 2.46866930 |
| 71 | Type II diabetes mellitus (HP:0005978) | 2.46795620 |
| 72 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.40908552 |
| 73 | Neonatal short-limb short stature (HP:0008921) | 2.40463324 |
| 74 | Cervical subluxation (HP:0003308) | 2.40290966 |
| 75 | Atrioventricular block (HP:0001678) | 2.39889536 |
| 76 | Peritonitis (HP:0002586) | 2.37614199 |
| 77 | Difficulty running (HP:0009046) | 2.36308077 |
| 78 | Spinal rigidity (HP:0003306) | 2.35916929 |
| 79 | Redundant skin (HP:0001582) | 2.33992299 |
| 80 | Abnormal auditory evoked potentials (HP:0006958) | 2.33328449 |
| 81 | Vitreoretinal degeneration (HP:0000655) | 2.31902866 |
| 82 | Broad metatarsal (HP:0001783) | 2.31194918 |
| 83 | Hyporeflexia of lower limbs (HP:0002600) | 2.28592400 |
| 84 | Exercise-induced muscle cramps (HP:0003710) | 2.26649771 |
| 85 | Abnormality of complement system (HP:0005339) | 2.26008776 |
| 86 | Complement deficiency (HP:0004431) | 2.22380351 |
| 87 | Thin bony cortex (HP:0002753) | 2.20432542 |
| 88 | Renal Fanconi syndrome (HP:0001994) | 2.20057675 |
| 89 | Increased hepatocellular lipid droplets (HP:0006565) | 2.19973087 |
| 90 | Retinitis pigmentosa (HP:0000510) | 2.19703497 |
| 91 | Spastic paraparesis (HP:0002313) | 2.17458925 |
| 92 | Spastic gait (HP:0002064) | 2.17091842 |
| 93 | Cerebral aneurysm (HP:0004944) | 2.15739251 |
| 94 | Muscle stiffness (HP:0003552) | 2.15542843 |
| 95 | Abnormality of the vitreous humor (HP:0004327) | 2.15426274 |
| 96 | White forelock (HP:0002211) | 2.14749858 |
| 97 | Aneurysm (HP:0002617) | 2.14617922 |
| 98 | Progressive visual loss (HP:0000529) | 2.14016185 |
| 99 | Distal lower limb amyotrophy (HP:0008944) | 2.11334552 |
| 100 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.09505638 |
| 101 | Hemorrhage of the eye (HP:0011885) | 2.07332719 |
| 102 | Dilatation of the ascending aorta (HP:0005111) | 2.07124710 |
| 103 | EMG: myopathic abnormalities (HP:0003458) | 2.06690717 |
| 104 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.06062068 |
| 105 | Flat face (HP:0012368) | 2.05231706 |
| 106 | Bladder diverticulum (HP:0000015) | 2.05139178 |
| 107 | Severe visual impairment (HP:0001141) | 2.02146210 |
| 108 | Cerebral palsy (HP:0100021) | 2.00397937 |
| 109 | Deep venous thrombosis (HP:0002625) | 1.99948268 |
| 110 | Patchy hypopigmentation of hair (HP:0011365) | 1.99765748 |
| 111 | Stomatitis (HP:0010280) | 1.99741159 |
| 112 | Abnormality of dentin (HP:0010299) | 1.99423825 |
| 113 | Epileptic encephalopathy (HP:0200134) | 1.98260221 |
| 114 | Malnutrition (HP:0004395) | 1.98155156 |
| 115 | Rhabdomyolysis (HP:0003201) | 1.97658948 |
| 116 | Wormian bones (HP:0002645) | 1.97500168 |
| 117 | Xanthomatosis (HP:0000991) | 1.97174057 |
| 118 | Eczematoid dermatitis (HP:0000976) | 1.95184351 |
| 119 | Abnormality of the parathyroid morphology (HP:0011766) | 1.95134087 |
| 120 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.93484322 |
| 121 | Abnormal ciliary motility (HP:0012262) | 1.90685244 |
| 122 | Type II lissencephaly (HP:0007260) | 1.90658009 |
| 123 | Dysmetria (HP:0001310) | 1.89110897 |
| 124 | Atrophic scars (HP:0001075) | 1.85819285 |
| 125 | Bulbar palsy (HP:0001283) | 1.85768277 |
| 126 | Megalencephaly (HP:0001355) | 1.85177258 |
| 127 | Emphysema (HP:0002097) | 1.84322679 |
| 128 | Biconcave vertebral bodies (HP:0004586) | 1.83887452 |
| 129 | Choroideremia (HP:0001139) | 1.83086092 |
| 130 | Febrile seizures (HP:0002373) | 1.81602255 |
| 131 | Soft skin (HP:0000977) | 1.81464594 |
| 132 | Ankle contracture (HP:0006466) | 1.80484079 |
| 133 | Leukodystrophy (HP:0002415) | 1.79342345 |
| 134 | Vaginal atresia (HP:0000148) | 1.78457966 |
| 135 | Decreased lacrimation (HP:0000633) | 1.77914229 |
| 136 | Parakeratosis (HP:0001036) | 1.77623662 |
| 137 | Joint stiffness (HP:0001387) | 1.77578477 |
| 138 | Optic disc pallor (HP:0000543) | 1.77525431 |
| 139 | Lipid accumulation in hepatocytes (HP:0006561) | 1.76174854 |
| 140 | Increased circulating renin level (HP:0000848) | 1.75855535 |
| 141 | Hypomagnesemia (HP:0002917) | 1.74994253 |
| 142 | Hyperuricemia (HP:0002149) | 1.74642407 |
| 143 | Increased purine levels (HP:0004368) | 1.74642407 |
| 144 | Aortic regurgitation (HP:0001659) | 1.74620159 |
| 145 | Posterior subcapsular cataract (HP:0007787) | 1.74221029 |
| 146 | Anomalous pulmonary venous return (HP:0010772) | 1.74099986 |
| 147 | Tubulointerstitial fibrosis (HP:0005576) | 1.73785702 |
| 148 | Abnormality of the calf musculature (HP:0001430) | 1.73572843 |
| 149 | Generalized myoclonic seizures (HP:0002123) | 1.72568880 |
| 150 | Nephritis (HP:0000123) | 1.71072027 |
| 151 | Hyperthyroidism (HP:0000836) | 1.70728779 |
| 152 | Absent epiphyses (HP:0010577) | 1.70564544 |
| 153 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.70564544 |
| 154 | Bowel incontinence (HP:0002607) | 1.70051010 |
| 155 | Ileus (HP:0002595) | 1.69432927 |
| 156 | Calf muscle hypertrophy (HP:0008981) | 1.69072639 |
| 157 | Abnormal pupillary function (HP:0007686) | 1.68330256 |
| 158 | Cupped ear (HP:0000378) | 1.68091570 |
| 159 | Blue sclerae (HP:0000592) | 1.67974127 |
| 160 | Spondylolisthesis (HP:0003302) | 1.67464868 |
| 161 | Stenosis of the external auditory canal (HP:0000402) | 1.65814479 |
| 162 | Septo-optic dysplasia (HP:0100842) | 1.65099115 |
| 163 | Genital tract atresia (HP:0001827) | 1.64646681 |
| 164 | Poor coordination (HP:0002370) | 1.64441118 |
| 165 | Calcaneovalgus deformity (HP:0001848) | 1.63811956 |
| 166 | Widely patent fontanelles and sutures (HP:0004492) | 1.63197457 |
| 167 | Myoglobinuria (HP:0002913) | 1.62674579 |
| 168 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.60899353 |
| 169 | Abnormality of incisor morphology (HP:0011063) | 1.60447652 |
| 170 | Gingivitis (HP:0000230) | 1.59782982 |
| 171 | Scapular winging (HP:0003691) | 1.59697010 |
| 172 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.59085864 |
| 173 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.58933154 |
| 174 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.58933154 |
| 175 | Shallow orbits (HP:0000586) | 1.58720268 |
| 176 | Joint hemorrhage (HP:0005261) | 1.58394013 |
| 177 | Congenital sensorineural hearing impairment (HP:0008527) | 1.58242265 |
| 178 | Hypoalphalipoproteinemia (HP:0003233) | 1.57555250 |
| 179 | Abnormality of renal resorption (HP:0011038) | 1.57035976 |
| 180 | Broad distal phalanx of finger (HP:0009836) | 1.56980327 |
| 181 | Ovoid vertebral bodies (HP:0003300) | 1.56978401 |
| 182 | Ventricular tachycardia (HP:0004756) | 1.56922030 |
| 183 | Bradycardia (HP:0001662) | 1.56524600 |
| 184 | Constricted visual fields (HP:0001133) | 1.56519377 |
| 185 | Limited hip movement (HP:0008800) | 1.55310509 |
| 186 | Deformed tarsal bones (HP:0008119) | 1.54496701 |
| 187 | Malignant hyperthermia (HP:0002047) | 1.54415734 |
| 188 | Flared iliac wings (HP:0002869) | 1.53923616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 6.00750060 |
| 2 | STK39 | 4.59390310 |
| 3 | IRAK2 | 4.01916201 |
| 4 | ERN1 | 4.00749326 |
| 5 | TTN | 3.55535160 |
| 6 | OBSCN | 3.33484840 |
| 7 | EPHA4 | 3.21173441 |
| 8 | IRAK1 | 3.14492291 |
| 9 | OXSR1 | 3.02417215 |
| 10 | RIPK1 | 2.98417358 |
| 11 | PRPF4B | 2.85525805 |
| 12 | TRIB3 | 2.40842853 |
| 13 | MYLK | 2.39619359 |
| 14 | IRAK4 | 2.29316845 |
| 15 | DDR2 | 2.12505343 |
| 16 | GRK1 | 2.11408968 |
| 17 | PDGFRA | 2.09709095 |
| 18 | FES | 2.09608868 |
| 19 | MST4 | 2.08840670 |
| 20 | MAP3K2 | 1.95656735 |
| 21 | FGFR2 | 1.95243800 |
| 22 | TGFBR2 | 1.93279320 |
| 23 | UHMK1 | 1.89290062 |
| 24 | SIK1 | 1.87440146 |
| 25 | EPHB2 | 1.83145858 |
| 26 | PKN1 | 1.78510235 |
| 27 | MAP2K3 | 1.77483120 |
| 28 | FGFR4 | 1.76871222 |
| 29 | PBK | 1.73258496 |
| 30 | CASK | 1.70388807 |
| 31 | PIK3CG | 1.66187036 |
| 32 | NEK9 | 1.62205354 |
| 33 | ZAP70 | 1.59702724 |
| 34 | DYRK1B | 1.57945702 |
| 35 | MAP3K7 | 1.54856330 |
| 36 | TYRO3 | 1.54483413 |
| 37 | MAPK13 | 1.50413397 |
| 38 | WNK4 | 1.49135413 |
| 39 | BMPR1B | 1.47568570 |
| 40 | TYK2 | 1.46549339 |
| 41 | FGR | 1.45959188 |
| 42 | EPHB1 | 1.45338482 |
| 43 | STK16 | 1.42951713 |
| 44 | CDC42BPA | 1.42713936 |
| 45 | PRKG2 | 1.41891401 |
| 46 | MAP3K6 | 1.38570733 |
| 47 | PRKD2 | 1.38086971 |
| 48 | PHKG2 | 1.36904447 |
| 49 | PHKG1 | 1.36904447 |
| 50 | MINK1 | 1.34863665 |
| 51 | GRK6 | 1.32822074 |
| 52 | MAP4K1 | 1.28801238 |
| 53 | MST1R | 1.27619858 |
| 54 | MARK1 | 1.23767743 |
| 55 | STK38 | 1.21363852 |
| 56 | PDGFRB | 1.13807104 |
| 57 | PTK6 | 1.13555858 |
| 58 | MAP3K3 | 1.11012831 |
| 59 | ABL2 | 1.09060004 |
| 60 | CDK19 | 1.08623916 |
| 61 | EPHA2 | 1.08387485 |
| 62 | ROCK2 | 1.08384843 |
| 63 | MARK2 | 1.08078502 |
| 64 | BCR | 1.07736763 |
| 65 | TESK1 | 1.06767208 |
| 66 | BMX | 1.06127153 |
| 67 | TNK2 | 1.04938100 |
| 68 | GRK7 | 1.01287453 |
| 69 | PTK2 | 0.99631727 |
| 70 | NTRK3 | 0.98170151 |
| 71 | PAK6 | 0.97352092 |
| 72 | ROCK1 | 0.97112422 |
| 73 | PAK3 | 0.96600982 |
| 74 | NTRK2 | 0.96549060 |
| 75 | EPHA3 | 0.92969075 |
| 76 | MET | 0.92851539 |
| 77 | CAMK2D | 0.91144883 |
| 78 | SGK223 | 0.90151709 |
| 79 | SGK494 | 0.90151709 |
| 80 | SRPK1 | 0.89956837 |
| 81 | TAOK2 | 0.89823527 |
| 82 | CHEK2 | 0.89636116 |
| 83 | PRKCQ | 0.89219510 |
| 84 | MAP2K7 | 0.89188923 |
| 85 | WNK1 | 0.89146532 |
| 86 | JAK1 | 0.88280551 |
| 87 | LATS1 | 0.87567190 |
| 88 | FGFR3 | 0.85400264 |
| 89 | KIT | 0.84854196 |
| 90 | CSK | 0.83841564 |
| 91 | CDK5 | 0.81557035 |
| 92 | TAOK1 | 0.79853856 |
| 93 | MAPK7 | 0.78302827 |
| 94 | KSR2 | 0.78018032 |
| 95 | CAMK2B | 0.76724202 |
| 96 | CAMK2A | 0.76340476 |
| 97 | MAPKAPK3 | 0.74618416 |
| 98 | IKBKE | 0.74562969 |
| 99 | INSR | 0.73527544 |
| 100 | MAP3K4 | 0.71396625 |
| 101 | PDK1 | 0.70882112 |
| 102 | RET | 0.69658897 |
| 103 | PRKCE | 0.69528010 |
| 104 | ADRBK1 | 0.68750153 |
| 105 | IRAK3 | 0.67622485 |
| 106 | ERBB3 | 0.67349651 |
| 107 | PKN2 | 0.67285334 |
| 108 | BMPR2 | 0.66792175 |
| 109 | RPS6KA2 | 0.66555328 |
| 110 | PIK3CA | 0.65935877 |
| 111 | MAP3K1 | 0.65716583 |
| 112 | YES1 | 0.64993560 |
| 113 | CSF1R | 0.64288309 |
| 114 | CLK1 | 0.64016727 |
| 115 | FYN | 0.62862351 |
| 116 | PLK2 | 0.62664415 |
| 117 | ACVR1B | 0.62474647 |
| 118 | PRKAA2 | 0.62240130 |
| 119 | ICK | 0.61628172 |
| 120 | TRPM7 | 0.60996583 |
| 121 | MAP3K13 | 0.59909247 |
| 122 | DYRK2 | 0.59298409 |
| 123 | GRK5 | 0.59044502 |
| 124 | RPS6KC1 | 0.58541642 |
| 125 | RPS6KL1 | 0.58541642 |
| 126 | PRKCG | 0.56874569 |
| 127 | LMTK2 | 0.55400923 |
| 128 | BTK | 0.55090455 |
| 129 | BLK | 0.55024274 |
| 130 | LYN | 0.54981326 |
| 131 | MKNK1 | 0.52865835 |
| 132 | MAP2K4 | 0.52511188 |
| 133 | PRKD1 | 0.52024625 |
| 134 | PAK4 | 0.51918159 |
| 135 | MELK | 0.51872735 |
| 136 | DAPK2 | 0.51708088 |
| 137 | NLK | 0.51661938 |
| 138 | MAP2K6 | 0.51609797 |
| 139 | LIMK1 | 0.51546024 |
| 140 | MAP3K11 | 0.50919978 |
| 141 | PRKAA1 | 0.49984006 |
| 142 | TESK2 | 0.49702084 |
| 143 | HCK | 0.48991195 |
| 144 | MTOR | 0.47916222 |
| 145 | PRKACA | 0.47366115 |
| 146 | MAPK11 | 0.46091563 |
| 147 | RPS6KA6 | 0.45712929 |
| 148 | NTRK1 | 0.45445365 |
| 149 | PRKCB | 0.45068491 |
| 150 | JAK2 | 0.44718742 |
| 151 | EEF2K | 0.44061694 |
| 152 | ERBB4 | 0.43838858 |
| 153 | NME1 | 0.42716686 |
| 154 | DMPK | 0.42081502 |
| 155 | MOS | 0.40536496 |
| 156 | PAK2 | 0.40092962 |
| 157 | PRKCH | 0.36259554 |
| 158 | MAPK12 | 0.36155841 |
| 159 | TBK1 | 0.36053803 |
| 160 | NEK6 | 0.33851233 |
| 161 | SGK1 | 0.32991429 |
| 162 | BRD4 | 0.32726843 |
| 163 | MAPKAPK5 | 0.32697837 |
| 164 | PRKCZ | 0.32368994 |
| 165 | PDPK1 | 0.32194913 |
| 166 | SRC | 0.31606031 |
| 167 | PTK2B | 0.29220232 |
| 168 | CAMK2G | 0.27820240 |
| 169 | AKT3 | 0.27618485 |
| 170 | RIPK4 | 0.27499844 |
| 171 | HIPK2 | 0.27319143 |
| 172 | PRKCA | 0.27232585 |
| 173 | CSNK1E | 0.27193867 |
| 174 | PRKG1 | 0.25839539 |
| 175 | ALK | 0.25731063 |
| 176 | PRKCD | 0.24462083 |
| 177 | IKBKB | 0.24176285 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 6.98347358 |
| 2 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.79036262 |
| 3 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 3.26533518 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.15322609 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.14690702 |
| 6 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.98377399 |
| 7 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.74009036 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.25410111 |
| 9 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.20560009 |
| 10 | * Glutamatergic synapse_Homo sapiens_hsa04724 | 2.12371243 |
| 11 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.99096779 |
| 12 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.98942832 |
| 13 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.97550955 |
| 14 | Circadian rhythm_Homo sapiens_hsa04710 | 1.94699014 |
| 15 | Axon guidance_Homo sapiens_hsa04360 | 1.92903166 |
| 16 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.89993087 |
| 17 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.88472954 |
| 18 | GABAergic synapse_Homo sapiens_hsa04727 | 1.86256154 |
| 19 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.85849929 |
| 20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.85141165 |
| 21 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.84712524 |
| 22 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 1.83976235 |
| 23 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.81360181 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.80551630 |
| 25 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.80402871 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.73892282 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.72605334 |
| 28 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.71357483 |
| 29 | Histidine metabolism_Homo sapiens_hsa00340 | 1.63949588 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.62270920 |
| 31 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.62190128 |
| 32 | Nicotine addiction_Homo sapiens_hsa05033 | 1.54558535 |
| 33 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.44741422 |
| 34 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.42750099 |
| 35 | Morphine addiction_Homo sapiens_hsa05032 | 1.39999918 |
| 36 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.38660475 |
| 37 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.36877460 |
| 38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.36556070 |
| 39 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.36066698 |
| 40 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.35255805 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.34578615 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.33553415 |
| 43 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.29135943 |
| 44 | Insulin resistance_Homo sapiens_hsa04931 | 1.21040868 |
| 45 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.20831581 |
| 46 | Focal adhesion_Homo sapiens_hsa04510 | 1.20451905 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.19310119 |
| 48 | Galactose metabolism_Homo sapiens_hsa00052 | 1.18913878 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.17923473 |
| 50 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.16942047 |
| 51 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.15486001 |
| 52 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.14016653 |
| 53 | Circadian entrainment_Homo sapiens_hsa04713 | 1.13604672 |
| 54 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.12137482 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 1.09447585 |
| 56 | Viral myocarditis_Homo sapiens_hsa05416 | 1.09219536 |
| 57 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.09212140 |
| 58 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.08728338 |
| 59 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.08571924 |
| 60 | Parkinsons disease_Homo sapiens_hsa05012 | 1.08113452 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.07686095 |
| 62 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.07126197 |
| 63 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.04332709 |
| 64 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98762768 |
| 65 | Long-term depression_Homo sapiens_hsa04730 | 0.93365821 |
| 66 | Pertussis_Homo sapiens_hsa05133 | 0.90998437 |
| 67 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.90652430 |
| 68 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89660598 |
| 69 | Malaria_Homo sapiens_hsa05144 | 0.85943032 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.85339370 |
| 71 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.85333876 |
| 72 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.84866036 |
| 73 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.84019989 |
| 74 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83885999 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.82655742 |
| 76 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81527496 |
| 77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.81204621 |
| 78 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80470986 |
| 79 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.80152047 |
| 80 | Olfactory transduction_Homo sapiens_hsa04740 | 0.79296391 |
| 81 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79222889 |
| 82 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.77858544 |
| 83 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.77362542 |
| 84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.77004981 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.75952190 |
| 86 | Taste transduction_Homo sapiens_hsa04742 | 0.75445790 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73690971 |
| 88 | Allograft rejection_Homo sapiens_hsa05330 | 0.73250205 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72802614 |
| 90 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.71834977 |
| 91 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.71587248 |
| 92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71496554 |
| 93 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.70490246 |
| 94 | Leishmaniasis_Homo sapiens_hsa05140 | 0.70100671 |
| 95 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.70042547 |
| 96 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.69394813 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.68917521 |
| 98 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.67422896 |
| 99 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66391521 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.65980527 |
| 101 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.64833741 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.64260305 |
| 103 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.63241480 |
| 104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63100178 |
| 105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62353024 |
| 106 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61324655 |
| 107 | Tight junction_Homo sapiens_hsa04530 | 0.61090654 |
| 108 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.60645676 |
| 109 | Huntingtons disease_Homo sapiens_hsa05016 | 0.59860259 |
| 110 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.59263739 |
| 111 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.58560074 |
| 112 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.58415549 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57791929 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.56826479 |
| 115 | Long-term potentiation_Homo sapiens_hsa04720 | 0.56725115 |
| 116 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.56595630 |
| 117 | Renin secretion_Homo sapiens_hsa04924 | 0.54401090 |
| 118 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53524162 |
| 119 | Lysosome_Homo sapiens_hsa04142 | 0.51939054 |
| 120 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.51908918 |
| 121 | Salivary secretion_Homo sapiens_hsa04970 | 0.51828779 |
| 122 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.51788769 |
| 123 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.51495933 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49968826 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.48929262 |
| 126 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.48262445 |
| 127 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.47877339 |
| 128 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.47621500 |
| 129 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.46884405 |
| 130 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.46505375 |
| 131 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.46282206 |
| 132 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.46211805 |
| 133 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.45173032 |
| 134 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.43422402 |
| 135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.43262400 |
| 136 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.43253693 |
| 137 | Hepatitis C_Homo sapiens_hsa05160 | 0.43251834 |
| 138 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41962114 |
| 139 | Phagosome_Homo sapiens_hsa04145 | 0.41760127 |
| 140 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.41683128 |
| 141 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.41380271 |
| 142 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.41077782 |
| 143 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.41058372 |
| 144 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.40974672 |
| 145 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.40102736 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.39713961 |
| 147 | Tuberculosis_Homo sapiens_hsa05152 | 0.39700608 |
| 148 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.39470463 |
| 149 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.37951875 |
| 150 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.37873479 |
| 151 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37532567 |
| 152 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.37382682 |
| 153 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.37085190 |
| 154 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36882643 |
| 155 | Peroxisome_Homo sapiens_hsa04146 | 0.36821945 |
| 156 | Insulin secretion_Homo sapiens_hsa04911 | 0.36480210 |
| 157 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.34278631 |
| 158 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.33469459 |
| 159 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.31867409 |
| 160 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.30884658 |
| 161 | Cocaine addiction_Homo sapiens_hsa05030 | 0.30750841 |
| 162 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.30642248 |
| 163 | Protein export_Homo sapiens_hsa03060 | 0.30107834 |
| 164 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.29742076 |
| 165 | Salmonella infection_Homo sapiens_hsa05132 | 0.28524274 |
| 166 | ABC transporters_Homo sapiens_hsa02010 | 0.27963864 |
| 167 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.27037421 |
| 168 | Metabolic pathways_Homo sapiens_hsa01100 | 0.25595362 |
| 169 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.24881257 |
| 170 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.24489184 |
| 171 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.23071922 |
| 172 | Mineral absorption_Homo sapiens_hsa04978 | 0.21954380 |
| 173 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.20791152 |
| 174 | Prostate cancer_Homo sapiens_hsa05215 | 0.20471619 |
| 175 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.19618434 |
| 176 | Gap junction_Homo sapiens_hsa04540 | 0.19334003 |
| 177 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.18449574 |

